Does PALBOCICLIB Cause Mucosal inflammation? 346 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 346 reports of Mucosal inflammation have been filed in association with PALBOCICLIB (Ibrance). This represents 0.4% of all adverse event reports for PALBOCICLIB.
346
Reports of Mucosal inflammation with PALBOCICLIB
0.4%
of all PALBOCICLIB reports
24
Deaths
51
Hospitalizations
How Dangerous Is Mucosal inflammation From PALBOCICLIB?
Of the 346 reports, 24 (6.9%) resulted in death, 51 (14.7%) required hospitalization, and 3 (0.9%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
Yes, Mucosal inflammation is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which PALBOCICLIB Alternatives Have Lower Mucosal inflammation Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID